Predictors of patient-perceived functional improvement after cardiac resynchronization therapy: a real-world multi-dimensional analysis of clinical, imaging, and ECG predictors

Résumé

Introduction Up to one-third of appropriately selected patients undergoing cardiac resynchronization therapy (CRT) fail to achieve meaningful clinical benefit despite fulfilling guidelines’ criteria. Traditional CRT response definitions [left ventricular (LV) end-systolic volume (ESV), ejection fraction (EF), and QRS duration] frequently diverge and occasionally fail to reflect patient-perceived clinical improvement. Objective To identify predictors for patient-perceived functional improvement after CRT, incorporating various clinical, biochemical, electrocardiographic (ECG), and imaging variables. Functional improvement was defined as the changes in New York Heart Association (NYHA) functional class 6-9 months after CRT implantation. Methods This retrospective single-center study included 97 heart failure (HF) patients meeting guideline-based CRT indications. Patients were categorized according to ≥1 NYHA class improvement at 6–9 months. Baseline and follow-up clinical, biochemical, ECG, echocardiographic, and cardiac magnetic resonance (CMR) parameters were compared between groups. Predictors of functional improvement were assessed using univariate and multivariate logistic regression. Results Sixty-eight patients (70%) achieved ≥1 NYHA class improvement. At baseline, the non-improved group was characterized by higher NT-proBNP and creatinine levels, longer PR and shorter QTc intervals, and worse LV and RV global longitudinal strain (GLS) on CMR. At follow-up, NT-proBNP remained elevated in the non-improved group. Traditional CRT response criteria were more frequently met in the improved compared to the non-improved group (>15% LV ESV reduction: 94.7% vs. 5.3%, >10% LV EF improvement: 98.1% vs. 1.9%, and >20 ms QRS shortening: 86.2% vs. 13.8%); but none independently predicted functional improvement in multivariate analysis. Independent predictors for ≥1 NYHA class improvement included baseline renal function (OR 1.19, 95% CI 1.00–1.39, p = 0.034), baseline LV GLS (OR 0.62, 95% CI 0.41–0.96, p = 0.030), and follow-up E/A ratio (OR 0.28, 95% CI 0.09–0.87, p = 0.028). Conclusion Functional improvement after CRT is best predicted by multi-dimensional assessment incorporating clinical, biochemical, and imaging parameters. In addition to the traditional response definitions, renal function, LV GLS, and LV diastolic indices were independently associated with a better patient-perceived functional improvement after CRT. Incorporating these factors into CRT eligibility and prognostication may enhance patient selection and improve outcomes.

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0